64 results
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
8 Aug 23
Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
4:15pm
also completed the 27-week chronic toxicity study of RGLS8429 in mice. No RGLS8429-related toxicity, including CNS effects, was observed at any dose … level up to the top dose of 300 mg/kg administered every other week. The Company plans to initiate the 39-week chronic toxicity study of RGLS8429
8-K
EX-99.1
hf1c b0y5intfkme
10 Nov 21
Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates
4:36pm
8-K
EX-99.1
pdb tgl6g
18 Oct 21
Other Events
6:06am
8-K
i6z od4s57cf4k3
12 Oct 21
Other Events
4:30pm
8-K
EX-99.1
mzg65v42uchcc8
21 May 21
Other Events
4:07pm
8-K
EX-99.1
afmpl 3xexo2cea38
1 Dec 20
Regulation FD Disclosure
8:40am